Literature DB >> 9382909

Rehospitalization with respiratory syncytial virus after neonatal intensive care unit discharge: A 3-year follow-up.

S A Nachman1, M Navaie-Waliser, M Z Qureshi.   

Abstract

OBJECTIVES: This study sought to determine 1) the incidence of rehospitalization with respiratory syncytial virus (RSV) infection within a 3-year follow-up among infants discharged from the neonatal intensive care unit (NICU), and 2) to examine associations between age at readmission and medical and sociodemographic characteristics among infants rehospitalized with RSV.
METHODS: A 3-year retrospective review of NICU discharges at a tertiary care center identified 2506 infants. Using medical record numbers linked with International Classification of Diseases, 9th ed, diagnostic codes for RSV infection, bronchiolitis, or respiratory distress, 67 NICU graduates were identified as having been readmitted from November to April (RSV season). Bivariate analyses and logistic regression modeling were applied to determine the association between a series of predictor variables and age at readmission with RSV by 90 days, 125 days, and 180 days after discharge from the NICU.
RESULTS: The 3-year incidence of readmission with RSV infection after NICU discharge was 2.7%. During the 3-year follow-up, 6.4% of very low birth weight infants, 2.8% of low birth weight infants, and 1.7% of normal weight infants were readmitted with RSV. Crude results revealed that the presence of bacteremia, intraventricular hemorrhage, and necrotizing enterocolitis, as well as ventilation use, were associated with younger age at readmission with RSV. Simultaneous consideration of the effects of all of these medical predictors and birth weight on age at readmission revealed that normal birth weight was the only significant factor associated with younger age at readmission with RSV.
CONCLUSIONS: This study found significantly lower rates of RSV readmission among NICU graduates than those reported previously in the literature. Based on these data, prophylactic treatment of all preterm infants may not be warranted.

Entities:  

Mesh:

Year:  1997        PMID: 9382909     DOI: 10.1542/peds.100.6.e8

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  Predictors and incidence of hospitalization due to respiratory syncytial virus (RSV)-associated lower respiratory tract infection (LRTI) in non-prophylaxed moderate-to-late preterm infants in Bosnia and Herzegovina.

Authors:  Hajrija Maksić; Suada Heljić; Fahrija Skokić; Darinka Šumanović-Glamuzina; Veroslava Milošević; Almir Zlatanović; Notario Gerard
Journal:  Bosn J Basic Med Sci       Date:  2018-08-01       Impact factor: 3.363

2.  Environmental exposures and respiratory morbidity among very low birth weight infants at 1 year of life.

Authors:  J S Halterman; K A Lynch; K M Conn; T E Hernandez; T T Perry; T P Stevens
Journal:  Arch Dis Child       Date:  2008-08-14       Impact factor: 3.791

3.  Epidemiology of respiratory syncytial virus infection in preterm infants.

Authors:  Bernhard Resch; Stefan Kurath; Paolo Manzoni
Journal:  Open Microbiol J       Date:  2011-12-30

4.  Simultaneous detection and differentiation of respiratory syncytial virus and other respiratory viral pathogens.

Authors:  Susan E Sefers; Haijing Li; Yi-Wei Tang
Journal:  Methods Mol Biol       Date:  2011

5.  An epidemiological study of respiratory syncytial virus associated hospitalizations in Denmark.

Authors:  Lone Graff Stensballe
Journal:  Respir Res       Date:  2002-06-24

6.  Use of Medical Resources by Preterm Infants Born at Less than 33 Weeks' Gestation Following Discharge from the Neonatal Intensive Care Unit in Korea.

Authors:  Jang Hoon Lee; Yun Sil Chang
Journal:  J Korean Med Sci       Date:  2015-10-27       Impact factor: 2.153

Review 7.  Respiratory Syncytial Virus Hospitalizations in Healthy Preterm Infants: Systematic Review.

Authors:  Josephine Mauskopf; Andrea V Margulis; Miny Samuel; Kathleen N Lohr
Journal:  Pediatr Infect Dis J       Date:  2016-07       Impact factor: 2.129

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.